• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔条技术:概述与未来潜力。

Oral strip technology: overview and future potential.

作者信息

Dixit R P, Puthli S P

机构信息

Drug Delivery Division, Panacea Biotec Ltd., Samarpan complex, Chakala, Andheri (East), Mumbai-400 099, Maharashtra, India.

出版信息

J Control Release. 2009 Oct 15;139(2):94-107. doi: 10.1016/j.jconrel.2009.06.014. Epub 2009 Jun 24.

DOI:10.1016/j.jconrel.2009.06.014
PMID:19559740
Abstract

Over the recent past, many of the research groups are focusing their research on this technology. Amongst the plethora of avenues explored for rapid drug releasing products, Oral Strip Technology (OST) is gaining much attention. The advantages of OST are the administration to pediatric and geriatric patient population where the difficulty of swallowing larger oral dosage forms is eliminated. This technology has been used for local action, rapid release products and for buccoadhesive systems that are retained for longer period in the oral cavity to release drug in controlled fashion. OST offers an alternate platform for molecules that undergo first pass metabolism and for delivery of peptides. The review article is an overview of OST encompassing materials used in OST, critical manufacturing aspects, applications, commercial technologies and future business prospects of this technology.

摘要

近年来,许多研究团队都将研究重点集中在这项技术上。在探索快速释药产品的众多途径中,口腔条带技术(OST)备受关注。OST的优势在于可用于儿科和老年患者群体,消除了吞咽较大口服剂型的困难。这项技术已用于局部作用、快速释药产品以及口腔粘附系统,这些系统可在口腔中保留较长时间以可控方式释放药物。OST为经历首过代谢的分子和肽类递送提供了一个替代平台。这篇综述文章概述了OST,包括OST中使用的材料、关键制造方面、应用、商业技术以及该技术的未来商业前景。

相似文献

1
Oral strip technology: overview and future potential.口腔条技术:概述与未来潜力。
J Control Release. 2009 Oct 15;139(2):94-107. doi: 10.1016/j.jconrel.2009.06.014. Epub 2009 Jun 24.
2
Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.口腔生物黏附给药——口服效率较低药物的一个有前景的选择。
J Control Release. 2006 Aug 10;114(1):15-40. doi: 10.1016/j.jconrel.2006.04.012. Epub 2006 Jul 7.
3
Oral osmotically driven systems: 30 years of development and clinical use.口服渗透压驱动系统:30 年的发展与临床应用。
Eur J Pharm Biopharm. 2009 Nov;73(3):311-23. doi: 10.1016/j.ejpb.2009.07.002. Epub 2009 Jul 12.
4
Advances in buccal drug delivery.口腔给药的进展。
Crit Rev Ther Drug Carrier Syst. 2005;22(3):295-330. doi: 10.1615/critrevtherdrugcarriersyst.v22.i3.20.
5
Drug delivery from the oral cavity: focus on a novel mechatronic delivery device.口腔给药:聚焦于一种新型机电给药装置。
Drug Discov Today. 2008 Mar;13(5-6):247-53. doi: 10.1016/j.drudis.2007.10.018. Epub 2007 Dec 11.
6
Advances in oral transmucosal drug delivery.口腔黏膜给药的新进展。
J Control Release. 2011 Jul 30;153(2):106-16. doi: 10.1016/j.jconrel.2011.01.027. Epub 2011 Feb 4.
7
Comprehensive review on oral disintegrating films.口腔崩解片的综合评述。
Curr Drug Deliv. 2013 Feb;10(1):96-108. doi: 10.2174/1567201811310010016.
8
Multiparticulate formulation approach to pulsatile drug delivery: current perspectives.用于脉冲式给药的多颗粒制剂方法:当前观点
J Control Release. 2009 Mar 4;134(2):74-80. doi: 10.1016/j.jconrel.2008.11.011. Epub 2008 Nov 24.
9
Advances in orodispersible films for drug delivery.口服分散片的给药进展。
Expert Opin Drug Deliv. 2011 Mar;8(3):299-316. doi: 10.1517/17425247.2011.553217. Epub 2011 Feb 2.
10
[Site-specific drug delivery systems II. Buccal delivery systems].[部位特异性给药系统II. 口腔给药系统]
Acta Pharm Hung. 2007;77(4):217-22.

引用本文的文献

1
Automated 3D Printing-Based Non-Sterile Compounding Technology for Pediatric Corticosteroid Dosage Forms in a Health System Pharmacy Setting.基于自动3D打印的医疗系统药房环境下儿科皮质类固醇剂型非无菌配药技术
Pharmaceutics. 2025 Jun 9;17(6):762. doi: 10.3390/pharmaceutics17060762.
2
Preliminary Study on the Development of Orodispersible Film Containing Desloratadine.含地氯雷他定口腔崩解片的研制初步研究
Turk J Pharm Sci. 2025 Mar 7;22(1):55-63. doi: 10.4274/tjps.galenos.2024.46116.
3
Formulation Design of Orally Disintegrating Film Using Two Cellulose Derivatives as a Blend Polymer.
以两种纤维素衍生物为共混聚合物的口腔崩解膜制剂设计
Pharmaceutics. 2025 Jan 10;17(1):84. doi: 10.3390/pharmaceutics17010084.
4
Assessing α-Bisabolol as a Transmucosal Permeation Enhancer of Buccal Local Anesthetics.评估α-红没药醇作为口腔局部麻醉药的透粘膜渗透促进剂
Pharmaceutics. 2024 Sep 12;16(9):1198. doi: 10.3390/pharmaceutics16091198.
5
Assessment of Alginate Gel Films as the Orodispersible Dosage Form for Meloxicam.海藻酸盐凝胶膜作为美洛昔康口腔崩解剂型的评估。
Gels. 2024 Jun 2;10(6):379. doi: 10.3390/gels10060379.
6
Influence of Casting Variables on Release Kinetics of Orally Disintegrating Film.铸造变量对口腔崩解膜释放动力学的影响。
Foods. 2024 May 5;13(9):1418. doi: 10.3390/foods13091418.
7
Biomaterials for Protein Delivery: Opportunities and Challenges to Clinical Translation.用于蛋白质递送的生物材料:临床转化的机遇与挑战
Micromachines (Basel). 2024 Apr 15;15(4):533. doi: 10.3390/mi15040533.
8
Pullulan-Based Spray-Dried Mucoadhesive Microparticles for Sustained Oromucosal Drug Delivery.基于普鲁兰多糖的喷雾干燥粘膜粘附性微粒用于口腔粘膜药物的持续递送
Pharmaceutics. 2024 Mar 26;16(4):460. doi: 10.3390/pharmaceutics16040460.
9
Hypromellose-, Gelatin- and Gellan Gum-Based Gel Films with Chlorhexidine for Potential Application in Oral Inflammatory Diseases.含氯己定的羟丙甲纤维素、明胶和结冷胶基凝胶膜在口腔炎症性疾病中的潜在应用
Gels. 2024 Apr 15;10(4):265. doi: 10.3390/gels10040265.
10
Evaluation of efficacy and safety profile of tadalafil 5 mg daily dose in the tablet form versus oral dispersible film in men with mild-to-moderate erectile dysfunction: a comparative placebo-controlled study.每日 5 毫克他达拉非片剂与口服分散片治疗轻中度勃起功能障碍男性患者的疗效和安全性评估:一项安慰剂对照研究。
Int Urol Nephrol. 2024 Aug;56(8):2531-2537. doi: 10.1007/s11255-024-04003-x. Epub 2024 Mar 4.